Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Cetuximab + Radiation / Radiotherapy (RT) & Head & Neck squamous cell carcinoma (HNSCC) is approved for the locally/regionally advanced, unresectable form by both FDA and EMA (1)
The clinical phase III trial NCT00004227 demonstrated that Cetuximab + Radiation / Radiotherapy (RT) significantly improves overall survival at 5 years compared with radiotherapy alone, confirming cetuximab + radiotherapy as an important treatment option in this group of patients. Cetuximab-treated patients with prominent …